Skip to main content
. 2017 Jul 20;20(7):490–498. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2017.07.08

2.

磨玻璃和部分实性结节影像学随访策略的区别

The difference of the follow-up strategies between the ground-glass nodules and part solid nodules

Item Ground-glass nodules (mm) Part-solid nodules (mm)
<5 ≥5 to<6 ≥6 <5 ≥5 to<6 ≥6 to<8 ≥8
2016 NCCN Guidelines No follow-up needed CT at 3 mo, and annual CT for at least 3 years CT at 3 mo, and annual CT for at least 3 years CT at 3 mo, and annual CT for at least 3 years Biopsy or surgical resection Biopsy or surgical resection Biopsy or surgical resection
2017 Fleischner Society Guidelines No follow-up needed No follow-up needed CT at 6-12 mo to confirm persistence, then CT every 2 years until 5 years No follow-up needed No follow-up needed CT at 3-6 mo to confirm persistence, if unchanged and solid component remains 6 mm, annual CT should be performed for 5 years CT at 3-6 mo to confirm persistence, if unchanged and solid component remains 6 mm, annual CT should be performed for 5 years
2013 ACCP Guidelines No follow-up needed Annual CT for at least 3 years Annual CT for at least 3 years CT at 3, 12, 24 mo, and then annual CT for at 1-3 years CT at 3, 12, 24 mo, and then annual CT for at 1-3 years CT at 3, 12, 24 mo, and then annual CT for at 1-3 years CT at 3 mo to confirm, persistencIf persistent, biopsy surgical resection if a nodule >15 mm at first CT scan,then biopsy, PET or surgical resection
2016 Clinical practice consensus guidelines for Asia Discuss role of continued surveillance with patient Annual CT surveillance for at least 3 years, consider ongoing annual CT surveillance after discussion with patient Annual CT surveillance for at least 3 years, consider ongoing annual CT surveillance after discussion with patient CT at 3, 12, 24 mo, and then annual CT surveillance CT at 3, 12, 24 mo, and then annual CT surveillance CT at 3, 12, 24 mo, and then annual CT surveillance CT at 3 mo, and consider antimicrobial therapy (nonsurgical or surgical biopsy consider PET scanning for staging before biopsy)